Millington Financial Advisors, LLC

Position in GANX — Gain Therapeutics, Inc.

CIK 1924615 NAPERVILLE, IL

Position in GANX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$30,450

+$1,350 QoQ

Shares Held

15,000

0.0% QoQ

Ownership

0.034%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#34

of 49 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Millington Financial Advisors, LLC holds $3,778,949 across 4 Biotechnology names. GANX ranks #4 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	29,229	$3,313,399
2	SLS	SELLAS Life Sciences Group, Inc.	25,000	$369,000
3	HELP	Cybin Inc.	10,000	$66,100
4	GANX	Gain Therapeutics, Inc. This page	15,000	$30,450

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$30,450	15,000	0.0%	Shares	Sole	2026-08-07
2026-03-31	$29,100	15,000	—	Shares	Sole	2026-05-08
No filing history on record for this holder in this stock.